First, I'm long cycc. I'm very pleasantly surprised by the pop, but I've read the PR a few times.
But Is it not talking about in vitro results? From what I read it looks like pre phase 1 study info. Which is great... But it puzzles me that it would pop on that and not on sapa AML or MDS data which is far closer to FDA approval. Am I wrong?
My thought rose colored glasses would say, it needed a little kindling and this positive info was the spark. @$3 it was being given virtually $0 for pipeline. And maybe this is a wakeup call. I think the PPS belongs $4 and with each passing day (esp if they get a positive DSMB safety check @ 200 patients), should cause this to drift higher, not lower.